FIELD: medicine.
SUBSTANCE: invention relates to medicine. Described is method of obtaining polymeric cement of medical purpose, which includes mixing of prescription quantity of powdery polymer, liquid monomer, antibacterial component and mixture mixing, as antibacterial componen applied is solution, which contains bacteriophage or mixture of several different bacteriophages, which have lytic activity, in concentration not less than 106 PFU/ml, in amount 5.0-6.5 wt %, which is introduced into cement after mixture cooling to temperature 4-10°C. Mainly applied is/are bacteriophage(s) against bacteria of genus Pseudomonas, Staphylococcus, Bacillus. In particular case, applied is/are bacteriophage(s), individually selected for particular pathogen, for this purpose typing of causative agent of infection process of bacterial etiology agent in particular patient is preliminarily carried out.
EFFECT: method insures incretion quality of target product by incretion of antibacterial properties of polymeric cement.
4 cl, 1 dwg, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| Pseudomonas aeruginosa BACTERIOPHAGE STRAIN USED AS BASE FOR PREPARING ASEPTIC FOR P AERUGINOSA | 2011 |
|
RU2455355C1 |
| METHOD FOR PREVENTION OF HEALTHCARE-ASSOCIATED INFECTIONS IN PATIENTS IN CHRONIC CRITICAL CONDITION | 2023 |
|
RU2818910C1 |
| METHOD FOR THE TREATMENT AND PREVENTION OF RECURRENCE OF NOSOCOMIAL PNEUMONIA | 2021 |
|
RU2794585C2 |
| STRAIN OF BACTERIOPHAGE Staphylococcus aureus SA20 ENSURING DESTRUCTION OF BIOFILMS CREATED BY BACTERIA OF Staphylococcus FAMILY | 2014 |
|
RU2565824C1 |
| BACTERIOPHAGE-CONTAINING ROOM DEODORANT | 2014 |
|
RU2574023C2 |
| ANTIBACTERIAL COMPOSITION (EMBODIMENTS) AND USE OF PROTEIN AS ANTIMICROBIAL AGENT DIRECTED AGAINST GRAM-NEGATIVE BACTERIA: PSEUDOMONAS AERUGINOSA, ACINETOBACTER BAUMANNII, KLEBSIELLA PNEUMONIAE AND SALMONELLA TYPHI (EMBODIMENTS) | 2019 |
|
RU2730615C1 |
| ANTIBACTERIAL COMPOSITION (EMBODIMENTS) AND USE OF PROTEIN AS ANTIMICROBIAL AGENT DIRECTED AGAINST BACTERIA PSEUDOMONAS AERUGINOSA, KLEBSIELLA PNEUMONIAE, ESCHERICHIA COLI, SALMONELLA TYPHI AND STAPHYLOCOCCUS HAEMOLYTICUS (EMBODIMENTS) | 2019 |
|
RU2730613C1 |
| ANTIBACTERIAL COMPOSITION (EMBODIMENTS) AND USE OF PROTEIN AS ANTIMICROBIAL AGENT DIRECTED AGAINST BACTERIA PSEUDOMONAS AERUGINOSA, KLEBSIELLA PNEUMONIAE, ESCHERICHIA COLI, SALMONELLA TYPHI AND STAPHYLOCOCCUS HAEMOLYTICUS (EMBODIMENTS) | 2019 |
|
RU2730614C1 |
| MODIFIED ENDOLYSIN AND ANTIBACTERIAL COMPOSITIONS BASED THEREON FOR TREATING INFECTIONS CAUSED BY ACINETOBACTER BAUMANNII, PSEUDOMONAS AERUGINOSA, KLEBSIELLA PNEUMONIAE, ESCHERICHIA COLI BACTERIA | 2023 |
|
RU2813626C1 |
| BACTERIOPHAGE STRAIN PSEUDOMONAS AERUGINOSA N 323 (500317), INTENDED FOR PREPARATION OF MONO- AND POLYVALENT TREATMENT-AND-PROPHYLACTIC PREPARATIONS OF BACTERIOPHAGES | 2019 |
|
RU2717451C1 |
